UCSF

Tagged: Department of Pharmaceutical Chemistry

Demanding change: 2019 Distinguished Alumnus Glen L. Stimmel, PharmD

“Challenging the status quo leads to very good things,” said Glen L. Stimmel, PharmD ’72, who has spent a career doing just that. As a motto, it has served him, and his profession, quite well.

Koda-Kimble Seed Award supports School of Pharmacy's boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy scientists unearth a new target for treating Parkinson’s disease

Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

CP159: Certificate in Resiliency Medicine Training: Immunizing for Stress

Sat Mar 9, 2019 - 8:30 am to 5:00 pm

About the course

We will explore the current research and demonstrate and practice resiliency building tools including a cross-section of mind-body interactions and internal narratives (story telling). Course completion requires teaching and modeling resiliency skills. Those who successfully complete the training will be awarded a certificate in resiliency training.

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

Creating an inexhaustible database for drug molecules

School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.

COSA Winter Auction

Wed Feb 20, 2019 - 4:30 pm to 8:00 pm

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Paul R. Ortiz de Montellano elected a fellow of the Royal Society of Chemistry

Ortiz de Montellano gained renown for his work with cytochrome P450 enzymes, which help the liver metabolize drugs and other chemicals, and regulate hormone levels.

Pages